Use of health care resources for varicella in the paediatric population, JordanMulticenter Study Published on 2021-02-252023-05-31 Journal: Eastern Mediterranean health journal = La revue de santé de la [Category] 두창, 수두, 홍역, [키워드] chicken pox Child Costs Inpatients Jordan outpatients [DOI] 10.26719/2021.27.2.159 [Article Type] Multicenter Study
Impact of coronavirus disease 2019 (COVID-19) on US Hospitals and Patients, April–July 2020코로나바이러스 질병 2019(COVID-19)가 미국 병원 및 환자에 미치는 영향, 2020년 4월–7월Original Article Published on 2021-02-192022-09-10 Journal: Infection Control and Hospital Epidemiology [Category] MERS, SARS, 치료기술, [키워드] center collected Control coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 hospitalization Critical declined disease control estimate Guidance hospital Hospitalization hospitalizations hospitalized patient hospitalized patients Impact IMPROVE Inpatient Inpatients magnitude mechanical ventilators module multiple imputation National National Healthcare Safety Network network NHSN number of inpatients outcome Patient proportion public health Quantitative Region respiratory Respiratory Coronavirus Safety SARS-CoV-2 South Spread Surveillance the United State The United States time United States ventilator virus Weighting with COVID-19 [DOI] 10.1017/ice.2021.69 PMC 바로가기 [Article Type] Original Article
Clinical characteristics of COVID-19 complicated with pleural effusionResearch Article Published on 2021-02-152022-10-28 Journal: BMC Infectious Diseases [Category] COVID-19, MERS, [키워드] analyzed C-reactive protein Characteristics Chest computed tomography clinical clinical feature Clinical features clinical outcomes clinically collected complementary COVID-19 COVID-19 patient Critical critical condition D-dimer described examined exhibited hemoglobin Hospital stay identify incidence Inpatients laboratory result lactic dehydrogenase LDH Lymphocytes mortality rate Neutrophils oxygen oxygen saturation Patient patients with PE physical Platelets pleural effusion Predictive Predictive model Prognosis regression analysis Result Retrospective study risk factor severe inflammation severity of COVID-19 the patient total bilirubin Virus Disease White blood cells [DOI] 10.1186/s12879-021-05856-8 PMC 바로가기 [Article Type] Research Article
Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients말초 림프구 수와 COVID-19 입원 환자의 사망률 사이의 연관성Research Article Published on 2021-02-112022-09-01 Journal: BMC Pulmonary Medicine [Category] Fulltext, MERS, 진단, [키워드] 95% CI Admission Analysis Characteristics clinical utility collected confounding factors coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients death death in COVID-19 decision curve analysis hospital hospitalized patient increased mortality Infection Inpatient Inpatients Laboratory tests lymphocyte Lymphocyte count Mortality mortality risk Multiple Multiple regression analysis Non-linear relationship outcome Patient peripheral lymphocyte prediction Predictive predictive power Predictive value regression analysis Result risk significantly higher supplementary material the patient threshold was used Wuhan [DOI] 10.1186/s12890-021-01422-9 PMC 바로가기 [Article Type] Research Article
Repurposed Antiviral Drugs for Covid-19 – Interim WHO Solidarity Trial ResultsCovid-19에 대한 용도 변경 항바이러스 약물 - WHO 연대 실험 잠정 결과Randomized Controlled Trial Published on 2021-02-112022-09-11 Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 임상, 치료제, [키워드] (rate ratio 28-day mortality 95% CI 95% confidence interval adherence age Analysis antiviral drug antiviral drugs assigned calculated Care coronavirus disease Coronavirus disease 2019 death drug drug regimen examined FIVE group Health Organization hospital Hospital stay Hospitalization hospitalized patient hospitalized patients Hydroxychloroquine in-hospital mortality indicated Inpatient Inpatients intention-to-treat interferon interferon beta Interferon beta-1a Interim interquartile range ISRCTN registry Kaplan-Meier Local Lopinavir mechanical ventilation median Mortality no effect occurred open overall mortality Pairwise comparison Patient patients hospitalized randomization Randomly rate ratio rate ratios receive receiving reduced regimen Remdesivir reported Result Solidarity trial Standard of care status Stratification the patient Treatment Trial Ventilation WHO World Health Organization [DOI] 10.1056/NEJMoa2023184 PMC 바로가기 [Article Type] Randomized Controlled Trial
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate dataCOVID-19와 관련된 뇌내 출혈의 특성: 개별 환자 및 집계 데이터에 대한 체계적인 검토 및 통합 분석Original Communication Published on 2021-02-052022-09-10 Journal: Journal of Neurology [Category] MERS, SARS, 치료기술, [키워드] 95% CI age aggregate Analysis anticoagulation cause causes Characteristics Clinical management Clinical treatment clinician Cohort studies cohort study COVID-19 Data analysis high mortality ICH implication incidence Inpatient Inpatients Intracerebral haemorrhage IQR lobar mechanism median median age Mortality observation Patient patient data patients with SARS-CoV-2 Prevalence Result searched severe COVID-19 stroke supplementary material symptomatic systematic review the median therapeutic treated trials with COVID-19 [DOI] 10.1007/s00415-021-10425-9 PMC 바로가기 [Article Type] Original Communication
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysisClinicalTrials.gov에 등록된 코로나바이러스 질병 2019에 대한 심혈관 요법을 평가하는 임상 시험의 특성: 횡단면 분석Article Published on 2021-02-012022-09-11 Journal: American heart journal [Category] SARS, 임상, [키워드] (defibrotide) aldosterone Analysis angiotensin Anti-inflammatory categories category Characteristics clinical care clinical trial clinical trials ClinicalTrials Cohort Colchicine Combination Complete Composite convalescent plasma COVID-19 COVID-19 treatment cross database defibrotide described disease drugs Enrollment Europe European evaluate evaluated Evidence extracorporeal membrane oxygenation Final followed by Generalizability Health Health policy implementation Inpatients lead less majority morbidity Mortality MOST network North North America outcomes participant Patient patients hospitalized plan platform Primary outcome protocol Randomized Registered Renin risk single center Sponsor study population therapeutic Therapies therapy Treatment trials were excluded with COVID-19 [DOI] 10.1016/j.ahj.2020.10.065 PMC 바로가기 [Article Type] Article
A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19Observational Study Published on 2021-02-012022-10-04 Journal: BMC Infectious Diseases [Category] MERS, 임상, [키워드] Care case sery cause children clinical Comorbidities Comorbidity Course COVID-19 COVID-19-related complications died discharge disease Germany hospital Inflammatory initial Inpatients intensive care invasive ventilation knowledge Mild MIS-C occur one patient outcome paediatric patient Patient Prospective Result risk SARS CoV-2 infection SARS-COV-2 infection Seven severe disease severe respiratory illness syndrome underlying disease while with COVID-19 [DOI] 10.1186/s12879-021-05791-8 PMC 바로가기 [Article Type] Observational Study
D-Dimer as a potential biomarker for disease severity in COVID-19COVID-19의 질병 중증도에 대한 잠재적 바이오마커로서의 D-DimerArticle Published on 2021-02-012022-09-11 Journal: The American journal of emergency medicine [Category] MERS, 바이오마커, [키워드] affected age Analysis Biomarker calculated characteristic clinical Computed tomography conducted COVID-19 COVID-19 diagnosis D-dimer D-dimer elevation D-dimer level D-dimer levels D-dimer value D-dimer values determine disease severity duration of hospitalization during treatment evaluated fibrinogen Follow-up Inpatient inpatient status Inpatients intensive care intensive care unit laboratory data lung lung involvement lymphocyte Mild neutrophil neutrophil count neutrophil lymphocyte ratio NLR outcome Patient patients patients with COVID-19 Platelet Pneumonia positive correlation positive correlations Predictive Predictive value Prognosis pulmonary Pulmonary embolism receiver operating characteristic ROC ROC analysis RT-PCR SARS-CoV-2 sensitivity severe pneumonia severity severity of COVID-19 specificity threshold Treatment utility Viral Viral pneumonia [DOI] 10.1016/j.ajem.2020.12.023 PMC 바로가기 [Article Type] Article
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialSARS-CoV-2 감염 치료를 위한 흡입 분무 인터페론 베타-1a(SNG001)의 안전성 및 효능: 무작위 배정, 이중 맹검, 위약 대조, 2상 시험Clinical Trial Published on 2021-02-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] 임상, 치료제, [키워드] 1:1 activities acute respiratory syndrome acute respiratory syndrome coronavirus adverse event adverse events Analysis assigned clinical clinical condition Clinical improvement clinical trials coronavirus COVID-19 symptoms death dose double-blind during treatment Efficacy Efficacy and safety FIVE greater hazard ratio headache hospital identify improvement Infection inhalation Inhaled Inpatient Inpatients intention-to-treat population interferon Interferon beta-1a MIU Multiple nine no infection Odds ratio Older Ordinal Scale oxygen oxygen supplementation Patient Phase 2 phase 2 trial Placebo placebo group placebo-controlled point-of-care positive RT-PCR Primary outcome randomised Randomly receive receiving Registered reported required respiratory Safety SARS-CoV-2 SARS-COV-2 infection scale Seven severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 statistical study drug substantial risk Symptoms the placebo group the WHO those receiving placebo Treatment treatment-emergent adverse event Trial trials WHO ordinal scale with COVID-19 [DOI] 10.1016/S2213-2600(20)30511-7 PMC 바로가기 [Article Type] Clinical Trial